This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: The Rockefeller University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ksenia Gnedeva - Innovator in Cellular Proliferation and Hearing Loss Treatment
Introduction: Ksenia Gnedeva is an accomplished inventor based in Malibu, California. She is currently affiliated with The Rockefeller University, where she contributes to groundbreaking research in the field of cellular proliferation and hearing loss treatment. Despite having no granted patents to her name, her innovative work is noteworthy.
Latest Patent Applications: Ksenia's latest patent applications include compositions and methods for cellular proliferation, specifically focusing on pyrrolopyridine-3- and 4-carboxamide compounds. These compounds, such as N-(3-substituted thiazaheterocyclylidene)-1H-pyrrolo[2,3-b]pyridine-3-carboxamides and N-(3-substituted thiazaheterocyclylidene)-1H-pyrrolo[2,3-b]pyridine-4-carboxamides, are designed to activate Yap and inhibit Lats kinases. Additionally, she has developed compositions aimed at ameliorating hearing loss, including N-(3-Substituted thiazol-2(3H)-ylidene)-1H-pyrrolo[2,3-b]pyridine-3-carboxamides. These innovative compounds hold promise for treating hearing loss effectively.
Conclusion: Ksenia Gnedeva is a dedicated inventor whose research at The Rockefeller University is paving the way for advancements in cellular proliferation and hearing loss treatment. Her contributions, although not yet reflected in granted patents, demonstrate her commitment to innovation in the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile